Recently Viewed

    GalectinTherapeutics

    Galectin Therapeutics Joined Nov 08, 2016

    Galectin Therapeutics Inc. (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.